Related Experiment Video
Updated: Jun 1, 2026
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780
Peter Solár1, Arthur J Sytkowski
1Laboratory for Cell Biology, Institute of Biology & Ecology, P.J. Šafárik University, Košice, Slovak Republic.
Abstract:
Ovarian cancer cells are usually initially sensitive to platinum-based chemotherapy, such as cisplatin (CDDP), but typically become resistant over time. Such drug resistance is a serious impediment to successful disease treatment, and the molecular mechanisms responsible for resistance are not fully understood. In search of novel mechanisms that may lead to the development of CDDP chemoresistance, we used subtractive hybridization to identify differentially expressed genes in CDDP resistant CP70 and C200 cells vs. CDDP sensitive A2780 human ovarian adenocarcinoma cells. We analyzed 256 randomly selected clones. Subtraction efficiency was determined by dot blot and DNA sequencing. Confirmation of differentially expressed cDNAs was done by virtual northern blot analysis, and 17 genes that were differentially expressed in CDDP resistant cell lines vs. CDDP sensitive A2780 cells were identified. The expression of 10 of these genes was low or undetectable in sensitive A2780 cells in comparison to resistant cells and an additional seven genes were more highly expressed in resistant CP70 and C200 vs. A2780 cells. Our identified genes are involved in numerous and diverse cellular processes, such as inhibition of apoptosis (ARHGDIB), stress response (HSPCA, TRA1), chromatin condensation (CNAP1, RanBP2), invasiveness of cells (MMP10), alteration of Ca(2+) homeostasis (ASPH, ATP2B1) and others. Further characterization of these genes and gene products should yield important insights into the biology of CDDP resistance in ovarian carcinoma.
Insights
Researchers identified 17 genes linked to cisplatin (CDDP) resistance in ovarian cancer. Understanding these genes, involved in apoptosis, stress, and cell invasion, may improve chemotherapy effectiveness.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer often develops resistance to platinum-based chemotherapy, like cisplatin (CDDP), hindering treatment success.
- The molecular mechanisms underlying CDDP chemoresistance in ovarian cancer are not fully elucidated.
- Identifying novel genes associated with chemoresistance is crucial for developing more effective therapeutic strategies.
Purpose of the Study:
- To identify novel genes and molecular mechanisms contributing to cisplatin (CDDP) resistance in human ovarian adenocarcinoma cells.
- To compare gene expression profiles between CDDP-sensitive and CDDP-resistant ovarian cancer cell lines.
- To provide insights into the biological processes involved in the development of CDDP chemoresistance.
Main Methods:
- Utilized subtractive hybridization to identify differentially expressed genes between CDDP-resistant (CP70, C200) and CDDP-sensitive (A2780) human ovarian cancer cells.
- Analyzed 256 randomly selected clones, with subtraction efficiency confirmed by dot blot and DNA sequencing.
- Confirmed differentially expressed complementary DNAs (cDNAs) using virtual northern blot analysis.
Main Results:
- Identified 17 genes exhibiting differential expression in CDDP-resistant versus CDDP-sensitive ovarian cancer cells.
- Ten identified genes were underexpressed in sensitive A2780 cells compared to resistant cells.
- Seven identified genes were overexpressed in resistant CP70 and C200 cells relative to A2780 cells.
Conclusions:
- The identified genes are implicated in diverse cellular functions, including inhibition of apoptosis, stress response, chromatin condensation, cell invasiveness, and calcium homeostasis.
- Further investigation of these differentially expressed genes and their products is essential for understanding CDDP resistance mechanisms in ovarian carcinoma.
- These findings may pave the way for novel therapeutic approaches to overcome chemoresistance in ovarian cancer patients.
Related Concept Videos
02:56Treatment Resistant Cancers
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...